How does the survival rates following radical cystectomy compare to other treatments for bladder cancer?

Updated: Nov 27, 2016
  • Author: Michael Christopher Large, MD; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print

In clinical stage T2 and T3 disease, external beam radiotherapy is associated with a 5-year survival rate of 20%-40%.

Bladder-sparing multimodal therapy (TURBT, radiation, chemotherapy) carries a 3- to 5-year survival rate of 45%-64%. Thus, the survival rate is comparable, although not superior, to radical cystectomy, and the burden of therapy is much higher for patients. In general, this approach is reserved for patients who are highly motivated toward bladder preservation.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!